Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FE9HY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,081
Award facts
- Contract value 100% obligated
- $16,081.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,081.26 to AmerisourceBergen Drug Corp for ORENCIA 125 MG/ML Syringe on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania. ORENCIA (abatacept) is a biologic immunosuppressant medication commonly used in the treatment of rheumatoid arthritis and other autoimmune conditions, indicating this order supports military healthcare requirements for specialized pharmaceutical products.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This single-award IDC serves as the primary vehicle through which Cencora supplies a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The competitively awarded delivery order reflects AmerisourceBergen's established capability as a critical pharmaceutical distributor for federal military medical procurement.
Quick answers
Who was awarded contract SPE2DR26FE9HY?
SPE2DR26FE9HY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FE9HY worth?
The government has obligated $16,081 on SPE2DR26FE9HY.
Is contract SPE2DR26FE9HY an order under another contract?
Yes. SPE2DR26FE9HY is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9HY competed?
The extent of competition for SPE2DR26FE9HY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award